The identification of molecules that can interact specifically with drug targets is an important step in the drug discovery process. Here, we describe a convenient and versatile method for the screening of compounds from plant products that can inhibit molecular interactions of interest. In this assay, enzymes, protein, or peptide ligands are fused to the amino terminus of bacterial alkaline phosphatase (BAP) using genetic engineering. These alkaline phosphatase fusion proteins are then used as one-step probes for detecting specific molecular interactions with various targets that are immobilized on the wells of a microtiter plate or membrane. Molecular interactions can be determined by colorimetric assay of alkaline phosphatase activity, which is highly specific and sensitive. Identification of compounds that can interfere with specific molecular interaction is determined from the reduction of signal from colorimetric analysis. Assays for different compounds at various conditions can be done at the same time. The cost for the assay is low and the technique is relatively easy. The identification of compounds that can antagonize specific molecular interactions should prove useful in the study of the nature of these interactions within the cell, as well as suggest leads for drug development. In addition, this assay can be applied to determine the mechanism of actions or to predict possible adverse reactions of plant-derived compounds.
INTRODUCTION
Precise molecular interactions between various molecules are crucial for normal growth, development, and function of living organisms. In addition to proteins, molecules that are involved in these interactions include lipids, carbohydrates, DNA, RNA, and other small substrates within the cell. Inappropriate interactions between these molecules can lead to various diseases. Recent advances in molecular cell biology and bioinformatics have led to the identification of numerous drug targets, which provide hope for more effective treatments in the future (Pillutla et al., 2002; Schreiber, 2000) . Once the drug targets have been identified, another important step is to identify molecules that can interact with these targets. The interaction can be either agonistic or antagonistic, depending on the existence of cellular abnormalities. Numerous techniques for identification of compounds that can specifically interact with drug targets have been reported (Drews, 2000; Hemmila and Hurskainen, 2002; Smith, 2002) . These include high-throughput screening from libraries of chemical compounds (Hertzberg and Pope, 2000; Williard et al., 1996; Wolcke and Ullmann, 2001 ), or rational design by computer modeling using information from 3D-structures of targets obtained via X-ray crystallography or NMR analysis (Bajorath, 2001; Beavers and Chen, 2002; Clark and Pickett, 2000; Schneider and Bohm, 2002; Walters and Murcko, 2002) . In addition to synthetic "small molecules" (Ganesan, 2002) , natural products are one of the most important sources of compounds for high-throughput screening (Newman et al., 2000; Raskin et al., 2002) . This article reports a convenient and versatile method for screening plant extracts that can specifically interact with drug targets of interest, using the 52 Bacterial Alkaline Phosphatase (BAP) fusion system (Yamabhai and Kay, 2001 ). The assay is rapid, specific, and highly sensitive. The cost for the screening is low and the technique is comparatively easy. It is also possible to perform assays for different compounds at the same time. The identification of compounds that can antagonize specific molecular interactions should prove useful in the study of the nature of these interactions in the cell, as well as suggest leads for drug development. In addition these assay can be applied to determine mechanism of actions or to predict adverse effects of plant extracts (Bandara and Kennedy, 2002) .
MATERIALS AND METHODS

Preparation of Bacterial Alkaline Phosphatase (BAP) Fusion Proteins
Alkaline phosphatase fusion proteins that will be used as one-step detection probe for the screening in this study were generated by genetic engineering. DNA encoding proteins of interest, ranging in size from 8 to 300 amino acids, were cloned in frame into SalI and XbaI sites of the pMY101 vector ( Fig. 1) (Yamabhai and Kay, 1997) . These constructs will generate fusion proteins where the target proteins of interest are linked to the N-terminus of bacterial alkaline phosphatase. To prepare for the fusion protein, a single colony of E. coli DH5α containing a recombinant plasmid was inoculated into 5-15 ml of LB medium containing 100 µg/ml of ampicillin, and allowed to grow overnight at 37°C. The BAP fusion proteins that were secreted into the culture media can be separated by centrifugation (1000xg for 5 min at 4°C) and kept at 4°C for 2-4 weeks.
Assay on Microtiter Plate
Target molecules were immobilized onto the wells of a microtiter plate as appropriate. The wells were then washed with TBS [25 mM Tris-HCl (pH 7.5), 145 mM NaCl, 3 mM KCl] containing 0.1% (v/v) Tween 20. To eliminate nonspecific binding, 10 µg of BSA in 100 µl TBS were added into each well and incubated for an additional hour. The wells were then washed and incubated with 150 µl of culture media containing appropriate BAP-fusion proteins for 1 hour at room temperature. Then, the wells were washed 5 times with TBS + 0.1% (v/v) Tween 20. The amount of bound BAP fusions were measured by adding 150 µl of pNPP (Sigma Fast) and quantifying the absorbance with a spectrophotometer at 405 nm. To screen for compounds that can inhibit the binding of BAP fusions to target molecules, compounds of interest were added into the wells containing culture media and processed as described above.
Assay on Membrane
To assay the binding of BAP fusions to molecules that were immobilized on a membrane, the membrane was first blocked with 10% BSA in TBS for 1 hour at room temperature. The membrane was then washed 3 times with TBS containing 0.1% (v/v) Tween 20 and incubated in culture media containing the appropriate BAP fusion for 1 hour at room temperature, or overnight at 4°C. The membrane was then washed 5 times with TBS + 10% (v/v) Tween 20 and incubated with NBT-BCIP (Sigma Fast) for 10 minutes and washed with de-ionized water. For chemiluminescent detection of the fusion proteins, the membrane was incubated with CSPD chemiluminescent substrate (Applied Biosystem, Foster city, CA, USA) and the signal was detected with Fluor-S Multimager (BioRad, Hercules, USA).
RESULTS AND DISCUSSION
Screening of Compounds Using BAP-fusion System
A convenient method for rapid screening of substances that can interfere with specific interactions has been developed. In this assay, molecular interaction between peptides that are fused to the N-terminus of bacterial alkaline phosphatase (BAP) and target molecules that are immobilized onto wells of a microtiter plate or membrane, can 53 be detected in less than 5 hours, as seen in Fig. 2 . BAP-fusion proteins can be prepared by simply inoculating bacteria containing recombinant plasmids encoding appropriate fusion proteins into 5-200 ml of LB media. Because the BAP fusion proteins contain a signal peptide at the N-terminus, the mature proteins will be secreted into the periplasmic space, and later into the culture media while the bacteria is growing overnight at 37°C. The BAP fusions then can be conveniently collected by centrifugation at 1000xg for 10 minutes. Culture supernatant containing BAP fusions can be kept at 4°C for 2-4 weeks. To detect molecular interactions, target molecules are first immobilized onto the wells of a microtiter plate or membrane. The nonspecific bindings are then blocked with BSA before target molecules are incubated with BAP fusions. After washing, bound BAP fusions that remain on the plate or membrane can be detected by various method of colorimetric or chemiluminescent analysis. Since the peptides are fused to the N-terminus of the bacterial alkaline phosphatase that protrudes out from the globular structure of the enzyme, peptides up to 300 amino acids long can be fused to BAP without interfering with its catalytic activity. To apply this system for screening compounds from plant extracts that can antagonize particular interactions, culture media containing BAP fusions are incubated in the presence of various concentrations of extracts. Certain compounds within plant extracts that interact with specific sites on either the target molecules or BAP fusions can interfere with the binding of BAP fusions to their targets. Thus, in these wells there will be no bound BAP fusions remaining after washing, resulting in no color development after the addition of alkaline phosphatase substrate.
Detection of Molecular Interactions on Microtiter Plate or Membrane
Alkaline phosphatase is a very convenient enzyme for detecting molecular interaction because there are abundant commercial substrates available for both qualitative and quantitative analysis. Different substrates are appropriate for various analyses, using either colorimetric or chemiluminescent detection. Fig. 3 illustrates two examples of detection formats that can utilize the BAP fusion system. In panel A, various GST fusion proteins were immobilized onto the wells of a microtiter plate. After blocking with BSA, the wells were incubated with different BAP fusion proteins; the wells were then washed, and the bound BAP fusion were detected with pNPP. The colorimetric reactions were permitted to develop until they reach an optical density (OD) of ~4.0 at 405 nm wavelength. Since the BAP fusions contain a FLAG peptide at the N-terminus, all of the fusion proteins will interact with anti-FLAG monoclonal antibodies that were immobilized onto the wells of the microtiter plate. This FLAG peptide serves as a convenient, internal positive control. The signal from colorimetric assay, using pNPP as a substrate, yields bright yellow color after 20 minutes of incubation. The color reaction can be allowed to develop overnight without the appearance of a background signal. Panel B demonstrates the detection of molecular interactions between BAP fusions and molecules that are immobilized on a membrane. Short peptides, 7 amino acids long, were synthesized as dots on Immobilon-P nylon membrane, the membrane was then blocked with 10% BSA and incubated with BAP fusions for 1 hour at room temperature. After washing, the membrane was incubated with CSPD substrate for 2 minutes, and the chemiluminescent signal was detected with Flour-S Multimager. The bound proteins on the membrane can be stripped off by incubating in 1% SDS at 60°C for 30 minutes and re-used several times. The results from these two different formats of detection suggest that BAP-fusion detection systems can be used to screen for plant extracts at various conditions as appropriate.
Detection of Compounds that Inhibit Specific Molecular Interaction
BAP-fusion systems can be used to screen for compounds that can inhibit specific molecular interactions. Fig. 4 demonstrates the inhibition curve of BAP fusion-target interactions at various concentrations of soluble peptides. GST fusion proteins were immobilized onto the wells of a microtiter plate, and incubated with different BAP fusion proteins in the presence of increasing amounts of soluble compounds (i.e. peptides).
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Compounds that compete with the binding of BAP fusions reduce the amount of bound BAP fusions that remain on the wells of microtiter plate after washing. Thus, wells that were incubated with these compounds will have less color development when incubated with alkaline phosphatase substrate. As seen in the different panels, various peptides have different abilities to inhibit interaction. The 50% inhibition concentration (IC 50 ) value can be estimated from the inhibition curve. Thus, the BAP fusion system can be used to screen for compounds that can inhibit specific molecular interactions, as well as to estimate the inhibition potential of each compound. In addition, this system can be used to determine specificity of the inhibitory effect of different compounds, which is the crucial property for good drug leads. As seen in Fig. 4 , peptides that can inhibit interaction to EH domains have no effect on the interaction with SH3 domains, suggesting that inhibition is not due to general inactivation of protein interaction, or disruption of catalytic activity of the enzymes. Since a screening with BAP fusion system can be done in a high-throughput format, one can screen for compounds that have specific inhibitory effects, while eliminating nonspecific interactions at the same time.
CONCLUSIONS
With the ability to display a wide range of polypeptides at the N-terminus of bacterial alkaline phosphatase, it is possible to detect molecular interactions in several formats. There are several kinds of alkaline phosphatase substrates available (i.e., soluble or insoluble, chemiluminescent or colorimetric), so a particular substrate can be chosen to suit specific needs. Furthermore, the utility of this system is enhanced by the fact that BAP fusion proteins are secreted from E. coli, and this culture medium can be used directly in experiments without further purification steps. Once the appropriate fusions have been constructed, the cells are simply grown overnight, and the fusion proteins are readily available in the culture supernatant. One interesting application of the BAP fusion system is its potential use in the drug discovery process. Once specific molecular interactions have been established as drug targets for certain diseases, the interactions can be adapted for testing with the BAP fusion system, which can then be applied to screen for inhibitory compounds from various plant extracts. In addition to searching for compounds that can inhibit specific molecular interactions, this system can be used to determine the mechanism of action, or to predict potentially adverse effects of plant extracts. In this case, various molecular interactions that have known physiological significance are tested with plant extracts to determine which interactions are inhibited by a particular plant extract. For example, a plant extract that can inhibit growth factor binding to the EGF receptor may suggest that this plant extract has an inhibitory effect on growth. Since screening for compounds with BAP-fusion system is easy and inexpensive, it is suitable to be used as the first step in screening for potential drug targets from plant extracts, prior to more sophisticated and costly steps that would need to be performed in a well-equipped laboratory. Figures   Fig. 1 . Map of BAP-fusion vector, pMY101. The DNA segment containing restriction sites (SalI and XbaI) for cloning is shown. The OmpA signal sequence for the secretion of fusion proteins into periplasmic space is upstream of the FLAG epitope. The vector carries genes for ampicillin resistance (amp r ) and the tac promoter, upstream of the bacterial alkaline phosphatase (BAP) gene. Fig. 2 . Schematic model for detecting molecular interactions using BAP fusion system. In panel A, protein targets are immobilized onto the wells of a microtiter plate or membrane. Peptides (from 8 to 300 amino acids long) are fused to the N-terminus of BAP. After washing, bound BAP fusions that remain bound to the targets can be detected by colorimetric or chemiluminescent substrates. In panel B, compounds from plant extracts are incubated with BAP fusions. After washing, wells that contain compounds that can compete with BAP fusion binding to its target will displace BAP fusion, so that no bound BAP fusion can be detected when colorimetric substrate is added. 
